Casey Lynch - Net Worth and Insider Trading
Casey Lynch Net Worth
The estimated net worth of Casey Lynch is at least $2 Million dollars as of 2024-11-09. Casey Lynch is the CEO of Quince Therapeutics Inc and owns about 1,120,580 shares of Quince Therapeutics Inc (QNCX) stock worth over $2 Million. Details can be seen in Casey Lynch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Casey Lynch has not made any transactions after 2021-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Casey Lynch
Casey Lynch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Casey Lynch owns 2 companies in total, including Quince Therapeutics Inc (QNCX) , and Longboard Pharmaceuticals Inc (LBPH) .
Click here to see the complete history of Casey Lynch’s form 4 insider trades.
Insider Ownership Summary of Casey Lynch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-05-10 | director & Chief Executive Officer |
| LBPH | Longboard Pharmaceuticals Inc | 2021-03-11 | director |
Casey Lynch Latest Holdings Summary
Casey Lynch currently owns a total of 1 stock. Casey Lynch owns 1,120,580 shares of Quince Therapeutics Inc (QNCX) as of May 10, 2021, with a value of $2 Million.
Latest Holdings of Casey Lynch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-05-10 | 1,120,580 | 1.70 | 1,904,986 |
Holding Weightings of Casey Lynch
Casey Lynch Form 4 Trading Tracker
According to the SEC Form 4 filings, Casey Lynch has made a total of 3 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 30,000 shares on May 10, 2021, which brought Casey Lynch around $1 Million.
Insider Trading History of Casey Lynch
- 1
Casey Lynch Trading Performance
Casey Lynch Ownership Network
Ownership Network List of Casey Lynch
Ownership Network Relation of Casey Lynch
Casey Lynch Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Casey Lynch is the director & Chief Executive Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Casey Lynch made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Casey Lynch Mailing Address
Above is the net worth, insider trading, and ownership report for Casey Lynch. You might contact Casey Lynch via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
